The Europe diabetes devices market size is expected to reach 8.7 billion by 2026, according to a new report by Grand View research, Inc. registering a CAGR of 4.0% over the forecast period. The size of the market is justified by the contribution from developed European economies such as Germany, U.K., France, and Italy. The prevalence of diabetes is rising amongst all ages in the European countries, mainly due to the unhealthy lifestyle, obesity, overweight, and physical inactivity. According to the International Diabetes Federation (IDF), around 66.0 million people in Europe are suffering from diabetes and this number is expected to increase to around 81.0 million by 2045. Thus, rising diabetes population base in this region is anticipated to be a major driver for the Europe diabetes devices market.
Additionally, the region is expected to witness high growth rate during the forecast period due to the continuous efforts towards diabetes control by the government and healthcare organizations such as the IDF. These organizations provide required expertise and support diabetes awareness campaigns through a network of stakeholders and partners. Also, increasing health care funding in the region is anticipated to propel the market’s growth.
Moreover, rising geriatric population is also anticipated to propel the market growth over the forecast period. In 2018, nearly one fifth of the Europe’s population was over 65 years age which is further fueling the diabetes device market. According to the United Nation report on World Population Aging, older population in Europe is projected to constitute 35.0% of total population by 2050. Furthermore, leading manufacturers are focusing on technological innovations and advanced product development to gain remarkable share in the market.
Browse full report with Table of Content @ https://www.grandviewresearch.com/industry-analysis/europe-diabetes-devices-market
Europe Diabetes Devices Market Report Highlights
• Germany held the largest market share owing to favorable reimbursement policies, local presence of key market players, and supportive government initiatives.
• In the self-monitoring and diagnostic devices segment, digital glucose monitors held the largest market size of 1.2 billion in 2018 and is growing at a CAGR of over 4.6% during the forecast period.
• Insulin pens held the largest market share in 2018 and the segment is projected to grow at a CAGR of 3.7% over the forecast period. The growth in this segment is attributed to ease of use and the ability to deliver accurate dosage.
• Insulin pumps segment is expected to grow during the forecast period. The segment is primarily driven by its advantage such as need of fewer injections to deliver insulin.
• Some of the prominent players include in Europe diabetes devices market are Eli Lilly and Company, Medtronic, Inc., Novo Nordisk A/S, Sanofi, Becton, Dickinson and Company, F. Hoffmann-La Roche, Ltd., B.Braun Melsungen AG, Ypsomed Holding AG, Abbott Laboratories and others.
For Requesting a Sample Copy of This Report, Please Visit @ https://www.grandviewresearch.com/industry-analysis/europe-diabetes-devices-market/request/rs1
Europe Diabetes Devices Market Segmentation
Grand View Research has segmented the Europe diabetes devices Market report on the basis of product and region.
Europe Diabetes Devices Product Outlook (Revenue, USD Million, 2015 - 2026)
• Monitoring and diagnostic devices
• Digital glucose monitors (DGM)
• Analog glucose monitors (AGM)
• Continuous Glucose Monitor (CGM)
• Insulin Delivery Devices
• Pens
• Pumps
• Syringes
• Jet injectors
Europe Diabetes Devices Regional Outlook (Revenue, USD Million, 2015 - 2026)
• Europe
• Germany
• U.K.
• Spain
• Italy
• France
• Poland
• Switzerland
• Austria
Inquire more or share questions if any before the purchase on this report @ https://www.grandviewresearch.com/inquiry/6730/ibb
Browse More Related Report:
Diabetes Devices Market Size, Share & Trends Analysis Report By Type (BGM Devices, Insulin Delivery Devices), By Distribution Channel, By End-use (Hospitals, Homecare), By Region, And Segment Forecasts, 2021 – 2028
About Grand View Research
Grand View Research is a market research and consulting company that offers market research reports, syndicated and customized reports. The company is headquartered in San Francisco, California. It offers client engagement for business consulting and market intelligence from various domains. The clientele is based across various countries with queries coming from more than 50 industries worldwide.
Grand View Research helps its clients to make informed decisions by helping them understand current trends and scenarios. Every year Grand View Research accomplishes more than 300 multi-country market studies to optimize consulting for clients.
Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist - U.S.A.
Email:Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States
Website: https://www.grandviewresearch.com/industry-analysis/europe-diabetes-devices-market
